Chest Email Content Delivery
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
QUICK SEARCH:   [advanced]


     

Guest Access | Sign In via User Name/Password
This Article
Right arrow Full Text (PDF) Free
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Article Archive
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dean, N.
Right arrow Articles by Matthay, M.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Dean, N.
Right arrow Articles by Matthay, M.

Chest, Vol 91, 619-620, Copyright © 1987 by American College of Chest Physicians

ARTICLES

Adult respiratory distress syndrome related to antilymphocyte globulin therapy

NC Dean, WC Amend and MA Matthay

A 21-year-old man developed the adult respiratory distress syndrome (ARDS) within five hours of receiving antilymphocyte globulin. No other identifiable cause of ARDS was present. The mechanism for development of acute lung injury is unknown, but may be related either to direct lung cytotoxicity or to complement-mediated leukocyte and platelet destruction with secondary lung injury from inflammatory mediators.


This article has been cited by other articles:


Home page
 Arch Intern MedHome page
G. D. Walton and R. J. Gualtieri
Antithymocyte Globulin-Induced Adult Respiratory Distress Syndrome
Arch Intern Med, June 22, 1998; 158(12): 1380 - 1380.
[Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1987 by the American College of Chest Physicians.